Appointment of Chief Executive Officer
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Mr. James brings extensive experience in healthcare and business transformation, having previously served as CEO of the Health Insurance Fund of Australia. His leadership is expected to enhance Vitura's focus on expanding patient access to specialty and emerging therapies. The filing also outlines Mr. James' remuneration details, including a base salary and performance incentives.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Vitura Health
- VIT enters distribution agreement with MedReleaf Australia
- H1 FY26 Investor Presentation
- H1 FY26 Results Release
- H1 FY26 Appendix 4D and Half Year Report
- CEO Transition and Interim Leadership Update
Later from Vitura Health
- Doctors on Demand Performance Update
- Business Transformation Update
- Former CEO Legal Action Initiated
- FY26 Results Investor Webinar
- ASX Appendix 4E Preliminary Final Report
Follow Vitura Health into a list and get an email when it puts out news.
Follow Vitura Health